Inserm, UMR-1162, Génomique fonctionnelle des Tumeurs solides, IUH, Paris, France; Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine, Paris, France; Service d'Hépatologie, Hôpital Jean Verdier, AP-HP, Bondy, France; Université Paris 13, Bobigny, France.
J Hepatol. 2015 Feb;62(2):477-82. doi: 10.1016/j.jhep.2014.11.015. Epub 2014 Nov 22.
The International Liver Cancer Association (ILCA) congress took place in Kyoto, Japan, from September 4 to 7, 2014 and ranged from basic to clinical studies in the area of primary liver cancer, including hepatocellular carcinoma (HCC), but also cholangiocarcinoma. In the field of basic and translational research, several studies attempted to refine our knowledge of biological events involved in liver carcinogenesis and sought to identify new therapeutic targets for improving clinical care in the future, Fig. 1. In the present work, a subjective selection of studies among the large number of abstract available at the ILCA meeting is presented and placed into context.
2014 年 9 月 4 日至 7 日，国际肝癌协会（ILCA）大会在日本京都举行，涵盖原发性肝癌（包括肝细胞癌[HCC]），但也包括胆管癌的基础和临床研究。在基础和转化研究领域，有几项研究试图细化我们对参与肝致癌发生的生物学事件的认识，并寻求确定新的治疗靶点，以改善未来的临床护理，图 1。在本工作中，从 ILCA 会议上提供的大量摘要中进行了主观选择研究，并将其置于上下文中。
